Combinatorial cancer immunotherapy (Q36490771)

14 August 2017

1 reference

title

Combinatorial cancer immunotherapy (English)

1 reference

14 August 2017

1 reference

F Stephen Hodi

1 reference

14 August 2017

Glenn Dranoff

1 reference

14 August 2017

publication date

1 January 2006

1 reference

14 August 2017

published in

Advances in Immunology

1 reference

14 August 2017

1 reference

14 August 2017

page(s)

341-368

1 reference

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Identification of an HLA-A3-restricted cytotoxic T lymphocyte (CTL) epitope from ML-IAP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The melanoma inhibitor of apoptosis protein: a target for spontaneous cytotoxic T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Two splicing variants of a new inhibitor of apoptosis gene with different biological properties and tissue distribution pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Novel therapeutic strategies for androgen-independent prostate cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Human tumor antigens recognized by T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Dendritic cells: a journey from laboratory to clinic

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Structural and kinetic basis for heightened immunogenicity of T cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Enhancing the immunostimulatory function of dendritic cells by transfection with mRNA encoding OX40 ligand.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The innate immune response to tumors and its role in the induction of T-cell immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Induction of cytotoxic T lymphocyte antigen 4 (CTLA-4) restricts clonal expansion of helper T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

GM-CSF-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cytokines in cancer pathogenesis and cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The immunobiology of cancer immunosurveillance and immunoediting

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Antigens derived from melanocyte differentiation proteins: self-tolerance, autoimmunity, and use for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cancer vaccines: between the idea and the reality

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Altered peptide ligand vaccination with Flt3 ligand expanded dendritic cells for tumor immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Helper strategy in tumor immunology: expansion of helper lymphocytes and utilization of helper lymphokines for experimental and clinical immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Mechanisms and functional significance of tumour-induced dendritic-cell defects

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Chromaffin granule membrane glycoprotein IV is identical with Ac45, a membrane-integral subunit of the granule's H(+)-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The makings of a tumor rejection antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The promise of cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The B7 family revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Granzyme B-mediated cytochrome c release is regulated by the Bcl-2 family members bid and Bax.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

ATP6S1 elicits potent humoral responses associated with immune-mediated tumor destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Biosynthesis of the vacuolar H+-ATPase accessory subunit Ac45 in Xenopus pituitary

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Control of autoimmunity by naturally arising regulatory CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The central role of CD4(+) T cells in the antitumor immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer: a phase I trial of safety and immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Livin, a novel inhibitor of apoptosis protein family member

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Chromosome arm 20q gains and other genomic alterations in colorectal cancer metastatic to liver, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

CpG motifs: the active ingredient in bacterial extracts?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

New insights into the role of 4-1BB in immune responses: beyond CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Immunotherapy for pancreatic cancer - science driving clinical progress

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Enhancement of antitumor immunity by CTLA-4 blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

KIAP, a novel member of the inhibitor of apoptosis protein family

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The inhibitors of apoptosis: there is more to life than Bcl2.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cytokine-secreting tumor cell vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Mechanism and control of class-switch recombination

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The basic science of gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

FOXP3 acts as a rheostat of the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

New paths in human cancer serology

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Dendritic cells as vectors for immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Immunotherapy via dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Spinning molecular immunology into successful immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Progress in human tumour immunology and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Human neoplasms elicit multiple specific immune responses in the autologous host

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitumor immunity in some patients with metastatic non-small-cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Autoimmunity in a phase I trial of a fully human anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody with multiple melanoma peptides and Montanide ISA 51 for patients with resected stages III and IV melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Targeting melanoma inhibitor of apoptosis protein with cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Melanoma inhibitor of apoptosis protein (ML-IAP) is a target for immune-mediated tumor destruction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Inhibition of the vacuolar H+-ATPase perturbs the transport, sorting, processing and release of regulated secretory proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A Gene Encoding Antigenic Peptides of Human Squamous Cell Carcinoma Recognized by Cytotoxic T Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Vaccination with irradiated, autologous melanoma cells engineered to secrete granulocyte-macrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Immunotherapy: bewitched, bothered, and bewildered no more

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Initiation of apoptosis by granzyme B requires direct cleavage of bid, but not direct granzyme B-mediated caspase activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Phase I study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stage IV renal cell cancer in Japan: clinical and immunological findings

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

DFF45/ICAD can be directly processed by granzyme B during the induction of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

The Emerging Role of CTLA-4 as an Immune Attenuator

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Tumor-specific shared antigenic peptides recognized by human T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accomp

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

A translational bridge to cancer immunotherapy: exploiting costimulation and target antigens for active and passive T cell immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

TNF/TNFR family members in costimulation of T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Detection of a potent humoral response associated with immune-induced remission of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Detection of autoantibodies to livin and survivin in Sera from lung cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Detection of anti-livin antibody in gastrointestinal cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Detection of autoantibodies to survivin and livin in sera from patients with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: in vivo persistence, migration, and antitumor effect of transferred T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Cloning, sequencing, chromosomal location, and function of cDNAs encoding an opioid growth factor receptor (OGFr) in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Granzymes A and B directly cleave lamins and disrupt the nuclear lamina during granule-mediated cytolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

Peptide-binding heat shock proteins in the endoplasmic reticulum: role in immune response to cancer and in antigen presentation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2776%2806%2990009-1

7 January 2021

10.1016/S0065-2776(06)90009-1

Identifiers

DOI

1 reference

14 August 2017

1 reference